Pilar Acedo
Principal Research Fellow / Group Leader
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (4)
Year:
2026
High-fat diet (HFD) and obesity are increasingly recognized as risk factors of pancreatic ductal adenocarcinoma (PDAC), yet the mechanisms by which dietary fat contribute to oncogenic transformation remain elusive. Using an inducible acinar-specific Kras G12V / Trp53 -loss genetically-engineered mouse model of PDAC, we established early-and late-onset protocols to assess age-dependent susceptibility to HFD. Specifically, HFD accelerated tumorigenesis with poorer prognosis in early-onset mice and, strikingly, enabled full PDAC development in late-onset adult mice otherwise resistant to oncogenic transformation. Tumors arising under HFD activated a distinct transcriptional and epigenetic state enriched in pathways or genes related to stemness, plasticity, and metastatic competence, which was maintained even in tumor-derived cell lines. Mechanistically, fatty acid-educated macrophages secreted the cathelicidin antimicrobial peptide (CAMP), activating P2X purinoceptor 7 (P2RX7) signaling in tumor cells to drive a highly plastic, immune-evasive phenotype reinforced by the expression of the peptidoglycan recognition protein 1 (PGLYRP1), further shielding tumor cells from macrophage phagocytosis. Functionally, HFD-induced tumors displayed enhanced metastatic potential independent of host context. Analysis of 164 human PDAC samples revealed that elevated body-mass index (BMI) was associated to a conserved CAMP-P2RX7-CXCR4 signature, maintained despite weight loss during disease progression. Together, these findings uncover a diet-imprinted macrophage-tumor cell circuit that promotes transformation and accelerates PDAC progression, positioning it as a therapeutic vulnerability in obesity-associated pancreatic cancer. Statement of significance High-fat diet induces pancreatic tumorigenesis in adult tissue, driving metastatic competence and a plastic state, and ultimately engages a macrophage-derived CAMP-P2RX7 circuit that reinforces immune evasion and accelerates PDAC progression.
Year:
2026
Year:
2025
A simple model for advancing the rapid construction of heavy-atom-free image-guided PDT agents for cancer treatment has been developed on the basis of using mitochondria targeting and BODIPY chemistry.
Year:
2024
Collaborators (10)
Alejandro Prieto-Castañeda
Lecturer / Assistant Professor in Chemistry and Organic Chemistry
Universidad Rey Juan Carlos
Carmine Carbone
Agostino Gemelli University Polyclinic
Shahram Kordasti
Clinical Haematologist
King’s College London
Stephen Pereira
University College London
Debashis Sarker
King’s College London
Carmen Guerra
"Científico Titular " (On leave of absence)
CSIC
Beth Russell
King’s College London
Claudio Luchini
Associate Professor of Pathology
University of Verona
Bruno Sainz Anding
Group Leader
Instituto Ramón y Cajal de Investigación Sanitaria
Manel Esteller
Group Leader, Cancer Epigenetics Group
Josep Carreras Leukaemia Research Institute
Make your next move.
Prepare your application
Review drafts before you send them.